Selecting Patients for Exclusive Permanent Implant Prostate Brachytherapy: The Experience of the Paris Institut Curie/Cochin Hospital/Necker Hospital Group on 809 Patients-Reference-Cited by-同舟云学术

Selecting Patients for Exclusive Permanent Implant Prostate Brachytherapy: The Experience of the Paris Institut Curie/Cochin Hospital/Necker Hospital Group on 809 Patients

Published:2008-07 Issue:4 Volume:71 Page:1042-1048
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Cosset Jean-Marc,Flam Thierry,Thiounn Nicolas,Gomme Stephanie,Rosenwald Jean-Claude,Asselain Bernard,Pontvert Dominique,Henni Mehdi,Debre Bernard,Chauveinc Laurent

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference46 articles.

1. Five-year biochemical outcome and toxicity with transperineal CT-planned permanent I-125 prostate implantation for patients with localized prostate cancer;Zelefsky;Int J Radiat Oncol Biol Phys,2000

2. Five-year outcome of intraoperative conformal permanent I-125 interstitial implantation for patients with clinically localized prostate cancer;Zelefsky;Int J Radiat Oncol Biol Phys,2007

3. Intermediate term biochemical-free progression and local control following 125iodine brachytherapy for prostate cancer;Stone;J Urol,2005

4. Disease-specific survival following the brachytherapy management of prostate cancer;Stock;Int J Radiat Oncol Biol Phys,2006

5. 12-year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer;Potters;J Urol,2005

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. French AFU Cancer Committee Guidelines - Update 2022-2024: prostate cancer - Diagnosis and management of localised disease;Progrès en Urologie;2022-11

2. ACR-ABS-ASTRO Practice Parameter for Transperineal Permanent Brachytherapy of Prostate Cancer;American Journal of Clinical Oncology;2022-05-06

3. Low dose rate brachytherapy for primary treatment of localized prostate cancer: A systemic review and executive summary of an evidence-based consensus statement;Brachytherapy;2021-11

4. Comparison of EBRT and I-125 seed brachytherapy concerning outcome in intermediate-risk prostate cancer;Strahlentherapie und Onkologie;2021-08-05

5. Tumor burden and location as prognostic factors in patients treated by iodine seed implant brachytherapy for localized prostate cancers;Radiation Oncology;2019-12-31